Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

Published:2008 Issue:11 Volume:122 Page:2612-2620
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ishikawa Nobuhisa,Hattori Noboru,Yokoyama Akihoto,Tanaka Sonosuke,Nishino Ryohei,Yoshioka Koji,Ohshimo Shinichiro,Fujitaka Kazunori,Ohnishi Hiroshi,Hamada Hironobu,Arihiro Koji,Kohno Nobuoki

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer Statistics, 2006

2. Epidermal Growth Factor Receptor Targeting in Cancer

3. Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

4. Epidermal growth factor receptor: mechanisms of activation and signalling

5. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of KL-6 in respiratory system diseases;Critical Reviews in Clinical Laboratory Sciences;2024-05-21

2. Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease;BMC Pulmonary Medicine;2024-03-15

3. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28

4. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer;Cancer Chemotherapy and Pharmacology;2023-08-22

5. Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia;BMC Pulmonary Medicine;2022-09-01